期刊
THERANOSTICS
卷 11, 期 3, 页码 1396-1411出版社
IVYSPRING INT PUBL
DOI: 10.7150/thno.53227
关键词
Hepatocellular carcinoma; KIAA1429; circular RNA; RNA-binding protein HuR; MMP1
资金
- National Key Technologies RD Program [2018YFC1106800]
- Natural Science Foundation of China [81972747, 81972204, 81872004, 81800564, 81770615, 81702327, 81700555, 81672882]
- Science and Technology Support Program of Sichuan Province [2019YFQ0001, 2018SZ0115, 2017SZ0003]
- Science and Technology Program of Tibet Autonomous Region [XZ201801-GB-02]
- 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University [ZYJC18008]
- Natural Science Foundation of Guangdong Province [2019A1515011097]
- Innovation Program of Shenzhen [JCYJ20180508165208399]
- Science and Technology Planning Project of Guangzhou [201904010089]
Our study demonstrates that circDLC1 is downregulated in HCC tissues and is closely associated with a favorable prognosis. Overexpression of circDLC1 inhibits proliferation and motility of hepatoma cells, while silencing of circDLC1 has the opposite effect. Mechanistically, circDLC1 binds to RNA-binding protein HuR, reducing the interaction between HuR and MMP1 mRNA, leading to inhibition of MMP1 expression and ultimately suppressing HCC progression.
Rationale: circular RNAs (circRNAs) have been demonstrated to play a crucial role in cancer progression. KIAA1429, a key component of the m6A methyltransferase complex, has recently been reported to promote hepatocellular carcinoma (HCC) progression by regulating the m6A methylation. The aim of present study is to investigate the role of circular RNAs in KIAA1429-mediated HCC progression. Methods: RNA sequencing (RNA-seq) and methylated RNA immunoprecipitation sequencing (m6A-seq) were utilized to identify KIAA1429-regulated circRNAs. The effects of circDLC1 on proliferation and metastasis of hepatoma cells were examined in vitro and in vivo. RT-qPCR was used to measure the expression of circDLC1 in HCC tissues and hepatoma cells. RNA FISH, RIP assays and biotin-labeled RNA pull-down were used to investigate the downstream effector of circDLC1. The downstream targets of circDLC1 were identified using RNA-seq. Results: Our data demonstrated that circDLC1 was downregulated in HCC tissues and closely relevant to favorable prognosis. Overexpression of circDLC1 inhibited the proliferation and motility of hepatoma cells in vitro and in vivo, while silencing of circDLC1 played the opposite role. Mechanistic investigations revealed that circDLC1 could bind to RNA-binding protein HuR, which subsequently reduced the interaction between HuR and MMP1 mRNAs, and thus inhibited the expression of MMP1, ultimately contributing to inhibition of HCC progression. Conclusion: Our work suggests that circDLC1, a downstream target of KIAA1429, is a promising prognostic marker for HCC patients, and the circDLC1-HuR-MMP1 axis may serve as a potential therapeutic target for HCC treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据